Public Dashboard: Morningstar 4 Bargains (9/11/2020)
These undervalued wide-moat stocks earn low uncertainty ratings. -- Susan Dziubinski
06/16/2025 | ||||||||||||
Company | Symbol | Shares | Price | Value | % of Total | Growth | Proj P/E | Proj Yield | Fin Str | EPS Stab | Qlty | PAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Averages | $557.64 | 3.4% | 14.3 | 2.6% | 68% | 62 | 67.2 | 7.7% | ||||
Coca-Cola | KO | 1.96 | $71.02 | $139.09 | 24.9% | 4.5% | 22.2 | 3.0% | 99% | 99 | 95 | 8.2% |
Novartis | NVS | 1.11 | $119.45 | $132.90 | 23.8% | 4.9% | 18.0 | 3.1% | 86% | 61 | 84 | 7.9% |
Pfizer | PFE | 2.77 | $24.54 | $68.03 | 12.2% | 2.8% | 10.0 | 4.2% | 90% | 57 | 80 | 12.9% |
Roche Holdings* | RHHBY | 2.21 | $41.24 | $91.16 | 16.3% | 4.3% | 20.1 | 3.5% | 75% | 95 | 83 | 13.7% |
Vanguard Total Stock Market | VTSMX | 1.22 | $104.05 | $126.46 | 22.7% | 0.0% | 0.0 | 0.0% | 0% | 0 | 0 | -0.1% |